Skip to main content
Premium Trial:

Request an Annual Quote

Biomedical Photometrics And Allelix Collaborate

Premium

WATERLOO, Ontario--An agreement signed last week will give Allelix Biopharmaceuticals early access to Biomedical Photometrics' patented Genescope technology for reading genetic microarrays. Allelix will evaluate a preproduction version of the Genescope instrument to help accelerate its existing drug discovery programs, and will provide funding during this period. Both companies will share the rights to any inventions developed during the collaboration.

The collaboration will allow BPI to shorten the Genescope commercialization period and to refine the technology to meet the specific needs of biotech researchers. BPI's primary focus is to develop an instrument for rapidly reading microarrays and gene chips that combines the highest possible fluorescence sensitivity with excellent spatial resolution and automatic scan control.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.